Dr. Jesus G Berdeja, MD

Claim this profile

Tennessee Oncology

Expert in Multiple Myeloma
Expert in Plasma Cell Neoplasm
19 reported clinical trials
25 drugs studied

About Jesus G Berdeja, MD

Education:

  • Obtained MD from the University of Texas Southwestern Medical School, graduating in 2001.
  • Completed Residency in Internal Medicine at Vanderbilt University Medical Center in 2004.
  • Finished Fellowship in Hematology/Oncology at Vanderbilt University Medical Center in 2007.

Experience:

  • Director of Myeloma Research and Senior Vice President of Clinical Research at Tennessee Oncology.
  • Professor of Medicine at Vanderbilt University Medical Center.

Area of expertise

1Multiple Myeloma
Global Leader
Jesus G Berdeja, MD has run 16 trials for Multiple Myeloma. Some of their research focus areas include:
t(4;14) positive
GOF mutation in MMSET positive
2Plasma Cell Neoplasm
Global Leader
Jesus G Berdeja, MD has run 16 trials for Plasma Cell Neoplasm. Some of their research focus areas include:
t(4;14) positive
GOF mutation in MMSET positive

Affiliated Hospitals

Image of trial facility.
Tennessee Oncology
Image of trial facility.
Sarah Cannon Cancer Center

Clinical Trials Jesus G Berdeja, MD is currently running

More about Jesus G Berdeja, MD

Clinical Trial Related3 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Jesus G Berdeja, MD has experience with
  • Dexamethasone
  • Daratumumab
  • Pomalidomide
  • Bortezomib
  • Carfilzomib
  • Iberdomide

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jesus G Berdeja, MD specialize in?
Jesus G Berdeja, MD focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved t(4;14) positive patients, or patients who are GOF mutation in MMSET positive.
Is Jesus G Berdeja, MD currently recruiting for clinical trials?
Yes, Jesus G Berdeja, MD is currently recruiting for 9 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Jesus G Berdeja, MD has studied deeply?
Yes, Jesus G Berdeja, MD has studied treatments such as Dexamethasone, Daratumumab, Pomalidomide.
What is the best way to schedule an appointment with Jesus G Berdeja, MD?
Apply for one of the trials that Jesus G Berdeja, MD is conducting.
What is the office address of Jesus G Berdeja, MD?
The office of Jesus G Berdeja, MD is located at: Tennessee Oncology, Nashville, Tennessee 37203-1625 United States. This is the address for their practice at the Tennessee Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.